Fair Value Calculator Fair Value Calculator
EN DE

1102 (1102) Fair Value & Analysis

Basic Materials · Market cap HK$182M

1 1102 1102 · HK
PriceHK$0.0650
Fair ValueHK$0.0488
Upside-25.0%
Quality54/100
Evidence: Medium Range HK$0.0488 – HK$0.0488

Fair value as of: Jul 2, 2026

From 22 valuation models · updated today

Share price −1.5% over the past month.

Price vs Fair Value (12 months)

HK$0.0720 HK$0.0420 Fair Value HK$0.0488 Jun 2025 Jun 2026

12‑month range HK$0.0420 – HK$0.0720 · the HK$0.0650 price screens above the HK$0.0488 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1102 (1102) currently trades at HK$0.0650, while our model-based Fair Value estimate is HK$0.0488 — implying the stock looks roughly 25.0% overvalued today. We read business quality at 54/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1102 generated revenue of HK$444M at a net margin of 0.2%. Revenue declined 7.8% year over year. It earns a return on equity of 17.2%. The balance sheet holds a net cash position of HK$33.7M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$444M
Revenue growth (YoY) -7.8%
Net margin 0.2%
Return on equity 17.2%
Free cash flow HK$2.6M FY2025
Operating margin 2.9%
More key figures
Net cash HK$33.7M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1102 reported revenue of HK$444M in FY2025 versus HK$322M in FY2021, a compound +8.4%/yr. Reported net income was HK$731K in FY2025.

Revenue +8.4%/yr
FY21 HK$322M
FY22 HK$270M
FY23 HK$532M
FY24 HK$462M
FY25 HK$444M
Net income
FY21 −HK$358M
FY22 −HK$257M
FY23 −HK$35.8M
FY24 −HK$24.4M
FY25 HK$731K

Is 1102 fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
CRH plc CRH $106.52 $64.08 -40%
Holcim AG HCMLY $18.75 $9.07 -52%
Heidelberg Materials AG HEI €185.15 €157.48 -15%
Vulcan Materials Company VMC $281.38 $116.17 -59%
Martin Marietta Materials, Inc MLM $609.88 $218.79 -64%
UltraTech Cement Limited ULTRACEMCO ₹10,912 ₹4,589 -58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1102 (1102) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0488 versus a price of HK$0.0650 — about −25% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1102?
Our model-based fair value for 1102 is HK$0.0488 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0650.
What is the quality score of 1102?
1102 has a Quality Score of 54/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1102 (1102)?
1102 reported trailing-twelve-month revenue of about HK$444M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1102?
The net profit margin of 1102 is about 0.2%, meaning it keeps roughly 0.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.